Hinge Health Inc - Class A

Research Hinge Health Inc - Class A (HNGE) on Bullrun: market cap USD 7.21B, P/E 69.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 7.21B; P/E is 69.2.

Peer valuation comparison

Latest P/E is 69.2x versus a Healthcare sector median of 24.46x (182.9% above).

Latest P/E is 69.2x versus a United States median of 24.87x (178.3% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 587.86M-USD 528.26MUSD 170.73M79.6%-7.77USD 208.00MUSD 8.04MUSD 178.66M
FY2024USD 390.40M-USD 11.93MUSD 47.96M76.8%-0.88USD 300.79Mn/a-USD 434.57M
FY2023USD 292.73M-USD 108.14M-USD 65.89M66.3%-8.31USD 234.95Mn/a-USD 423.99M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 7.21B69.2n/an/a
20252025-12-31USD 3.68Bn/an/an/a

About Hinge Health Inc - Class A

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Hinge Health Inc - Class A's market cap?

Hinge Health Inc - Class A's market capitalization is USD 7.21B.

What is Hinge Health Inc - Class A's P/E ratio?

Hinge Health Inc - Class A's price-to-earnings (P/E) ratio is 69.2.

What does Hinge Health Inc - Class A do?

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.